Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
30.58
+0.78 (2.62%)
Oct 31, 2025, 4:08 PM HKT

HKG:2591 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023
Period Ending
Jun '25 Dec '24 Dec '23
Net Income
-221.89-174.69-733.38
Depreciation & Amortization
11.2716.7619.54
Other Amortization
0.170.170.1
Loss (Gain) From Sale of Assets
-0.3-
Loss (Gain) From Sale of Investments
0.08-0.19-1.13
Stock-Based Compensation
19.9916.04538.9
Other Operating Activities
-9.77-12.58-8.43
Change in Inventory
-33.8-25.590.23
Change in Accounts Payable
58.842.7115.64
Change in Other Net Operating Assets
14.2914.463.92
Operating Cash Flow
-169.42-162.62-164.6
Capital Expenditures
-5.04-3.95-12.05
Sale (Purchase) of Intangibles
-2.24-0.38-0.15
Investment in Securities
218.1280.28-145.02
Investing Cash Flow
210.82275.95-157.21
Short-Term Debt Issued
-9.91
Total Debt Issued
49.939.91
Short-Term Debt Repaid
--1-1
Long-Term Debt Repaid
--0.81-4.45
Total Debt Repaid
-12.31-1.81-5.45
Net Debt Issued (Repaid)
37.618.1-4.45
Issuance of Common Stock
-250367.81
Other Financing Activities
-3.62-3.26-11.66
Financing Cash Flow
34254.84351.71
Foreign Exchange Rate Adjustments
0.250.70.71
Net Cash Flow
75.64368.8730.61
Free Cash Flow
-174.46-166.57-176.64
Free Cash Flow Per Share
-0.41-0.40-0.46
Cash Interest Paid
0.430.872.32
Levered Free Cash Flow
--95.73-
Unlevered Free Cash Flow
--95.18-
Change in Working Capital
30.73-8.4119.79
Source: S&P Global Market Intelligence. Standard template. Financial Sources.